[144] CLARIVATE PLC SEC Filing

A shareholder of Clarivate (CLVT) has filed a Form 144 notice to sell up to 309,902 shares of common stock.

Rhea-AI Filing Summary

A shareholder of Clarivate (CLVT) has filed a Form 144 notice to sell up to 309,902 shares of common stock. The proposed sale, to be executed through Morgan Stanley Smith Barney LLC on the NYSE, has an aggregate market value of $1,160,273.09. The filing lists an approximate sale date of 12/01/2025. The shares come from restricted stock acquired from the issuer on 03/01/2025 and 05/01/2025 in amounts of 37,793 and 272,109 shares, respectively, and are being sold against a total of 661,435,069 shares outstanding.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Clarivate (CLVT) disclose in this Form 144 filing?

The filing reports that a shareholder of Clarivate (CLVT) intends to sell up to 309,902 common shares under Rule 144, providing details on the shares, broker, market value, and timing of the planned sale.

How many Clarivate (CLVT) shares are proposed to be sold and what is their value?

The notice covers up to 309,902 shares of Clarivate common stock with an aggregate market value of $1,160,273.09 based on the figures in the filing.

When is the planned sale date for the Clarivate (CLVT) shares in this Form 144?

The approximate date of sale listed is 12/01/2025, indicating when the shareholder expects to begin selling the shares, subject to market conditions and Rule 144 requirements.

Through which broker and exchange will the Clarivate (CLVT) shares be sold?

The filing states that the common shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE.

How were the Clarivate (CLVT) shares in this Form 144 originally acquired?

The shares were acquired as restricted stock from the issuer. The filing lists 37,793 shares acquired on 03/01/2025 and 272,109 shares acquired on 05/01/2025, both with payment described as not applicable.

How many Clarivate (CLVT) shares are outstanding according to this notice?

The Form 144 indicates that there are 661,435,069 shares of Clarivate common stock outstanding, providing context for the size of the proposed sale.

What representation does the selling shareholder make in this Clarivate (CLVT) Form 144?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about Clarivate's current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/01/2025 - 04:34 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001972847
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CLARIVATE PLC
SEC File Number	001-38911
Address of Issuer	70 St. Mary Axe London UNITED KINGDOM EC3A 8BE
Phone	44 207 4334000
Name of Person for Whose Account the Securities are To Be Sold	BAR VEINSTEIN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	309902	1160273.09	661435069	12/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/01/2025	Restricted Stock	ISSUER			37793	03/01/2025	Not Applicable
Common	05/01/2025	Restricted Stock	ISSUER			272109	05/01/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	12/01/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/05/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Bar Veinstein
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)